Rasmus H. Olsen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis After Initiation of Antiseizure Medication: A Danish Nationwide Cohort Study.

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis After Initiation of Antiseizure Medication: A Danish Nationwide Cohort Study.

Journal: Neurology

Published: July 17, 2026

Lorazepam during breastfeeding: a pharmacokinetic case report and exploratory pharmacovigilance assessment - a contribution from the ConcePTION project.

Lorazepam during breastfeeding: a pharmacokinetic case report and exploratory pharmacovigilance assessment - a contribution from the ConcePTION project.

Journal: Frontiers in pharmacology

Published: May 10, 2026

Isotretinoin is not associated with elevated risk of pseudotumor cerebri: A Danish register-based cohort study.

Isotretinoin is not associated with elevated risk of pseudotumor cerebri: A Danish register-based cohort study.

Journal: Journal of the American Academy of Dermatology

Published: April 27, 2026

Isotretinoin is not associated with elevated risk of pseudotumor cerebri: A Danish register-based cohort study.

Isotretinoin is not associated with elevated risk of pseudotumor cerebri: A Danish register-based cohort study.

Journal: Journal of the American Academy of Dermatology

Published: April 27, 2026

Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow-Up.

Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow-Up.

Journal: The Journal of dermatology

Published: July 30, 2025

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study.

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 19, 2025

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use.

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use.

Journal: Basic & clinical pharmacology & toxicology

Published: April 29, 2025

Titel: Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study.

Titel: Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study.

Journal: Pharmacoepidemiology and drug safety

Published: April 10, 2025

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding.

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding.

Journal: British journal of clinical pharmacology

Published: December 21, 2024

Reevaluating the role of interferon-beta in psoriasis pathogenesis: A registry-based self-controlled study.

Reevaluating the role of interferon-beta in psoriasis pathogenesis: A registry-based self-controlled study.

Journal: The Journal of dermatology

Published: May 02, 2024

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger

Published: March 27, 2024

Monitoring and treatment of hypercholesterolemia after an atherosclerotic cardiovascular disease event in Denmark from 2015 to 2020.

Monitoring and treatment of hypercholesterolemia after an atherosclerotic cardiovascular disease event in Denmark from 2015 to 2020.

Journal: International journal of cardiology

Published: September 04, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026